CABG better than PCI in diabetes patients on insulin, study finds

11/1/2013 | Medscape (free registration)

Diabetes patients with multivessel disease who underwent coronary artery bypass graft surgery had lower rates of all-cause mortality, nonfatal myocardial infarction or nonfatal stroke than those who underwent percutaneous coronary intervention, according to a review presented at the Transcatheter Cardiovascular Therapeutics meeting. Researchers also found that both insulin-dependent and non-insulin-dependent patients who had CABG showed lower rates of major adverse cardiovascular events at five years compared with the PCI arm.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA